![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
| Item Type: | Article |
|---|---|
| Title: | Genetic deletion of the purinergic receptor P2rx7 worsens the phenotype of α‑sarcoglycan muscular dystrophy |
| Creators Name: | Astigiano, Cecilia, Principi, Elisa, Pintus, Sara, Benzi, Andrea, Baratto, Serena, Panicucci, Chiara, Passalacqua, Mario, Sierra-Marquez, Juan, Nicke, Annette, Antonini, Francesca, Del Zotto, Genny, Cicatiello, Annunziata Gaetana, Raffaghello, Lizzia, Rezzonico Jost, Tanja, Grassi, Fabio, Bruzzone, Santina, Bruno, Claudio and Gazzerro, Elisabetta |
| Abstract: | Limb-girdle muscular dystrophy R3 (LGMDR3), a rare genetic disorder characterized by progressive impairment of limb, diaphragmatic, and respiratory muscles, is caused by loss-of-function mutations in the α-sarcoglycan gene (SGCA) and aggravated by immune-mediated damage and fibrotic tissue replacement. Pharmacological inhibition of purinergic receptor P2X7 (P2X7R) reduced inflammation and fibrosis in Sgca(-/-) mice. To further define the role of P2X7R, we generated a double knockout mouse model Sgca(-/-) P2rx7(-/-). We compared diaphragms isolated from 24-week-old Sgca(-/-) P2rx7(+/+) and Sgca(-/-) P2rx7(-/-) mice since the diaphragmatic muscle is early and severely damaged by Sgca genetic loss-of-function. Unexpectedly, Sgca(-/-) P2rx7(-/-) mice displayed increased extracellular matrix deposition and augmented cellularity in fibrotic areas, in particular, a higher number of CD3(+) lymphocytes and Iba1(+) macrophages compared to Sgca(-/-) P2rx7(+/+) mice. Moreover, intense P2X4R signal colocalized with CD3(+) and Iba1(+) cells, confirming its expression by these infiltrating immune cells. Absence of an improvement of the dystrophic phenotype was histologically confirmed in Sgca(-/-) P2rx7(-/-) quadriceps, although the fibrotic reaction was milder than that in diaphragms, suggesting a differential influence of the tissue microenvironment on the receptor functions. Flow cytometric analysis of limb muscle-infiltrating immune cells revealed a decrease in NK cells. Motor performance tests did not reveal any difference between the two genotypes. In conclusion, this study identified a divergent outcome of genetic deletion of the P2rx7 gene as compared to P2X7R blockade in α-sarcoglycan dystrophic tissue, suggesting that pharmacological interventions targeting the P2X7R in dystrophic immune-mediated damage require careful definition of a precise time window and dosage. |
| Keywords: | α-Sarcoglicanopathy, LGMDR3, P2X7R, Skeletal Muscle, Fibrosis, Inflammation, Animals, Mice |
| Source: | ACS Pharmacology & Translational Science |
| ISSN: | 2575-9108 |
| Publisher: | American Chemical Society |
| Volume: | 8 |
| Number: | 10 |
| Page Range: | 3477-3489 |
| Date: | 10 October 2025 |
| Official Publication: | https://doi.org/10.1021/acsptsci.5c00138 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
